A design strategy to generate a SARS‐CoV‐2 RBD vaccine that abrogates ACE2 binding and improves neutralizing antibody responses

Overview of attention for article published in European Journal of Immunology, July 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#29 of 6,782)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 7 news outlets

twitter: 4 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 3 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 18,337 followers.

I´m happy to present you our latest publication: https://t.co/UCeiq772Oo Here we explain a new vaccine design that can improve the immune response by eliciting higher neutralizing antibodies in vivo. Go check it out!

25 Jul 2023

Reply Repost Favourite

RT @smnlssn: Excited to see this collaboration with Kathrin de la Rosa's lab (@MDC_Berlin @ChariteBerlin) out on designing improved SARS-Co…

14 Jul 2023

Reply Repost Favourite

RT @smnlssn: Excited to see this collaboration with Kathrin de la Rosa's lab (@MDC_Berlin @ChariteBerlin) out on designing improved SARS-Co…

14 Jul 2023

Reply Repost Favourite

Excited to see this collaboration with Kathrin de la Rosa's lab (@MDC_Berlin @ChariteBerlin) out on designing improved SARS-CoV-2 vaccines. https://t.co/RW2eLd7ALr

14 Jul 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.